About Simcere Pharma
Simcere Pharma is a company based in Nanjing (China) founded in 1995. The company has 6,580 employees as of December 31, 2024. Simcere Pharma offers products and services including Anti-tumor Drugs and Nervous System Drugs.
- Headquarter Nanjing, China
- Employees 6580 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Simcere Pharmaceutical Group Limited
-
Annual Revenue
$925.77 M (USD)-1.47as on Dec 31, 2024
-
Net Profit
$102.35 M (USD)0.65as on Dec 31, 2024
-
EBITDA
$171.25 M (USD)40.45as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
6580
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Simcere Pharma
Simcere Pharma is a publicly listed company on the HKEX with ticker symbol 2096 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Simcere Pharma
Simcere Pharma offers a comprehensive portfolio of products and services, including Anti-tumor Drugs and Nervous System Drugs.
Anti-tumor drugs are developed and marketed by Simcere for various cancer treatments.
Nervous system drugs are provided by Simcere for conditions like insomnia and related disorders.
People of Simcere Pharma
Unlock access to complete
Funding Insights of Simcere Pharma
Detailed funding history for Simcere Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Simcere Pharma
Investment portfolio details for Simcere Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Simcere Pharma
Detailed financials for Simcere Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Simcere Pharma Comparisons
Peer comparison for Simcere Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Simcere Pharma
Detailed competitors of Simcere Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Simcere Pharma
Complete news archive for Simcere Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Simcere Pharma
Simcere Pharma was founded in 1995.
Simcere Pharma is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
As of Dec 31, 2024, the latest employee count at Simcere Pharma is 6,580.
Annual revenue of Simcere Pharma is $925.77M as on Dec 31, 2024.
Simcere Pharma was founded in 1995 and is headquartered in Nanjing, China, within the pharmaceutical sector. Research, development, and commercialization of treatments for cancer and autoimmune diseases are conducted. The pipeline features antibody-drug conjugates and biologics directed at disease-specific pathways. Manufacturing and distribution networks are maintained to support products, and research partnerships are formed to advance therapy timelines for patients.
Simcere Pharma offers Anti-tumor Drugs and Nervous System Drugs.
Yes, Simcere Pharma is publicly traded on HKEX under the ticker symbol 2096.
The ticker symbol of Simcere Pharma is 2096 on HKEX.